Advertisement
Advertisement

BDRX

BDRX logo

Biodexa Pharmaceuticals plc - ADR

4.25
USD
Sponsored
-0.61
-12.55%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

4.35

+0.10
+2.35%

Biodexa Pharmaceuticals plc - ADR Profile

About

BIODEXA PHARMA is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3(TM) platform for delivering therapeutics across the blood-brain barrier and the treatment of central nervous system disorders in areas of high unmet medical need. BIODEXA PHARMA, formerly known as Midatech Pharma plc, is based in NEW HAVEN, Conn.

Info & Links

CEO

Stephen Stamp

Headquarters

1 CASPIAN POINT, CASPIAN WAY
CARDIFF, X0 CF10 4DQ, UNITED KINGDOM

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.biodexapharma.com

Auditor

PKF Littlejohn LLP

Share holders

183

Employees

11

Biodexa Pharmaceuticals plc - ADR Statistics

Valuation Measures

Market Capitalization2

2.82M

Enterprise Value

-8.35M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.03

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.11

52-Week Change

-93.97%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

451.64K

Dividend Yield

0.00%

Float4

136.00K

% Held by Insiders

0.34%

% Held by Institutions

17.51%

Balance Sheet

Total Cash(mrq)

11.25M

Total Cash Per Share(mrq)

24.92

Total Debt(mrq)

80.40K

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

2.03%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement